Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. AVIR

Market Cap: $424.94M

AI

Atea Pharmaceuticals, Inc.

AVIR
NASDAQUSD
Purchase AVIR
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Executive

Jean-Pierre Sommadossi

Founder, Chairman, Chief Executive Officer & President

Compensation
$1,125,584
Andrea J. Corcoran

Chief Financial Officer, Executive Vice President of Legal & Secretary

Compensation
$810,818
Adel Moussa

Executive Vice President of Chemistry

Compensation
Compensation not disclosed
Jayanthi Wolf

Executive Vice President of Regulatory Affairs

Compensation
Compensation not disclosed
Keith Pietropaolo

Executive Vice President of Clinical Sciences & Project Management

Compensation
Compensation not disclosed
Nancy Gail Berry Agrawal

Executive Vice President of Preclinical Development

Compensation
Compensation not disclosed
Wayne Foster

Executive Vice President of Finance & Chief Accounting Officer

Compensation
$580,463
Xiao-Jian Zhou

Executive Vice President of Early Stage Development

Compensation
Compensation not disclosed
Jonae R. Barnes

Senior Vice President of Investor Relations & Corporate Communications

Compensation
Compensation not disclosed
Laura Ishak

Senior Vice President of Clinical Operations

Compensation
Compensation not disclosed
Qi Huang

Senior Vice President of Virology

Compensation
Compensation not disclosed
Janet J. Hammond

Chief Development Officer

Compensation
$870,794
John F. Vavricka

Chief Commercial Officer

Compensation
$634,437
Maria Arantxa Horga

Chief Medical Officer

Compensation
$747,102